New study to explore the health impacts of COVID-19 on people who use drugs

New study to explore the health impacts of COVID-19 on people who use drugs

Understanding the health impacts of the COVID-19 pandemic on people who use drugs in Scotland is the focus of a new University of Stirling study. The project - funded under the Scottish Government's Rapid Research in COVID-19 programme - will assess the longer-term health impacts of the social response to the pandemic on people who use drugs (PWUD). The research will consider whether a reduction in the availability of illicit drugs has changed purchasing habits - resulting in an increased risk for some - and look at how others may have reduced or ceased drug use to avoid social contact. Led by Professor Catriona Matheson, of the Faculty of Social Sciences, the research team will look at the impact of the virus on three distinct elements of drug use and services in Scotland: distribution and social use patterns of illicit drugs; the availability of harm reduction services; and the provision of addiction treatment services and the impact on people in recovery. The study will also consider whether changes to drug service provision, introduced due to COVID-19, exposes PWUD to harm through a heightened risk of overdose or relapse. Feedback received by the Drug Deaths Taskforce suggests a number of issues are beginning to emerge for people who use drugs - because of the virus and the measures being used to combat it. This is the only research of its type and its findings will be provided to policymakers, service providers, and organisations representing people who use drugs to help shape their responses to these challenges. Being able to understand how people's drug purchasing and using behaviours are affected by social distancing will be vitally important to informing pragmatic risk reduction messages for this group." Professor Catriona Matheson, Chair of the Scottish Drug Deaths Taskforce Related Stories



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More